menu
    • menu

    Company profile for Kalaris Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kalaris is a biopharmaceutical company founded by experienced leaders in ophthalmology drug development and commercialization. We are dedicated to addressing the unmet need in treating retinal diseases. While current therapies preserve vision, their frequent clinic visits place a heavy burden on patients and caregivers, often resulting in suboptimal outcomes. Kalaris is developing a novel therapy designed to ease this burden a...
    Kalaris is a biopharmaceutical company founded by experienced leaders in ophthalmology drug development and commercialization. We are dedicated to addressing the unmet need in treating retinal diseases. While current therapies preserve vision, their frequent clinic visits place a heavy burden on patients and caregivers, often resulting in suboptimal outcomes. Kalaris is developing a novel therapy designed to ease this burden and enhance patient outcomes, offering a more effective and convenient treatment option.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kalaris TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Palo Alto, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kalaristx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kalaris Appoints Leone Patterson as Chair of Audit Committee
    Kalaris Appoints Leone Patterson as Chair of Audit Committee

    04 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/04/3055898/0/en/Kalaris-Expands-Board-of-Directors-Appointing-Leone-Patterson-as-Chair-of-Audit-Committee.html

    GLOBENEWSWIRE
    04 Apr 2025
    Share Share
    Kalaris Announces Closing of Merger with AlloVir
    Kalaris Announces Closing of Merger with AlloVir

    18 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/18/3044996/0/en/Kalaris-Announces-Closing-of-Merger-with-AlloVir.html

    GLOBENEWSWIRE
    18 Mar 2025
    Share Share
    Kalaris and AlloVir Announce Stockholder Approval of Merger
    Kalaris and AlloVir Announce Stockholder Approval of Merger

    12 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/12/3041732/0/en/Kalaris-and-AlloVir-Announce-Stockholder-Approval-of-Merger.html

    GLOBENEWSWIRE
    12 Mar 2025
    Share Share
    AlloVir & Kalaris Announce Merger Focused on Retina Diseases
    AlloVir & Kalaris Announce Merger Focused on Retina Diseases

    08 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/08/2977479/0/en/AlloVir-and-Kalaris-Therapeutics-Announce-Agreement-for-Transformational-Merger-to-Create-Company-Focused-on-Diseases-of-the-Retina.html

    GLOBENEWSWIRE
    08 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search